{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T04:31:58Z","timestamp":1786509118923,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Postgraduates ' innovative scientific research project of colleges and universities in Hainan Province","award":["Qhys2023-498"],"award-info":[{"award-number":["Qhys2023-498"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cytokeratin 19 (CK19), Ki67 antigen (Ki67), and \u03b2-catenin are abnormally overexpressed in hepatocellular carcinoma (HCC), but their diagnostic and prognostic value remains unclear. This study aims to investigate the predictive role of these three markers in post-operative survival of HCC patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The expression levels of CK19, Ki67, and \u03b2-catenin in HCC tumor tissues were determined through public datasets. Kaplan-Meier survival analysis and multivariate Cox regression were performed to evaluate their prognostic value. Immunohistochemistry and Western blotting were used to detect the expression levels of CK19, Ki67, and \u03b2-catenin in hepatocellular carcinoma tissues and adjacent non-cancerous tissues. Transcriptome sequencing was performed to analyze the differential transcriptional changes between HCC and adjacent non-cancerous tissues. A cohort of HCC post-operative patients was included to analyze the correlation between the three markers and clinical pathological features.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>CK19, Ki67, and \u03b2-catenin were highly expressed in HCC tissues and lowly expressed in adjacent non-cancerous tissues. High expression of CK19, Ki67, and \u03b2-catenin was closely associated with poor disease-free survival (DFS) and overall survival (OS) in HCC patients\u2019 post-surgery. These three markers serve as independent prognostic factors for DFS and OS. Immunohistochemistry and Western blotting revealed upregulation of CK19, Ki67, and \u03b2-catenin in HCC tissues, while transcriptome sequencing indicated alterations related to metabolic reprogramming, immune evasion, and invasion\/metastasis in HCC. Clinical data from HCC patients showed that CK19 expression correlated with tumor number and differentiation grade, Ki67 expression correlated with patient age, tumor size, tumor number, lymphatic metastasis, and tumor differentiation, while \u03b2-catenin expression was closely related to tumor diameter, number, and capsule status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>CK19, Ki67, and \u03b2-catenin are highly expressed in HCC and can serve as molecular markers for post-operative recurrence and poor survival in HCC patients, providing a basis for precise prognostic evaluation in HCC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-025-15429-6","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T08:58:19Z","timestamp":1765529899000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Elevated expression of CK19, Ki67, and \u03b2-Catenin as prognostic biomarkers in hepatocellular carcinoma"],"prefix":"10.1186","volume":"26","author":[{"given":"Hongjiu","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianghui","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"issue":"1","key":"15429_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41572-021-00245-6","volume":"7","author":"Hepatocellular carcinoma","year":"2021","unstructured":"Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(1):7.","journal-title":"Nat Rev Dis Primers[J]"},{"issue":"12","key":"15429_CR2","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/s41571-023-00825-3","volume":"20","author":"AG Singal","year":"2023","unstructured":"Singal AG, Kanwal F, Llovet JM. Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy. Nat Rev Clin Oncol. 2023;20(12):864\u201384.","journal-title":"Nat Rev Clin Oncol[J]"},{"issue":"11","key":"15429_CR3","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.3390\/cancers14112798","volume":"14","author":"E Chakraborty","year":"2022","unstructured":"Chakraborty E, Sarkar D. Emerging therapies for hepatocellular carcinoma (HCC). Cancers. 2022;14(11):2798.","journal-title":"Cancers"},{"issue":"6","key":"15429_CR4","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1067\/j.cpradiol.2015.04.004","volume":"44","author":"T Clark","year":"2015","unstructured":"Clark T, Maximin S, Meier J, et al. Hepatocellular carcinoma: review of epidemiology, screening, imaging diagnosis, response assessment, and treatment. Curr Probl Diagn Radiol. 2015;44(6):479\u201386.","journal-title":"Curr Probl Diagn Radiol"},{"issue":"3","key":"15429_CR5","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.annonc.2019.12.001","volume":"31","author":"LT Chen","year":"2020","unstructured":"Chen LT, Martinelli E, Cheng AL, et al. Pan-Asian adapted ESMO clinical practice guidelines for the management of patients with intermediate and advanced\/relapsed hepatocellular carcinoma: a TOS-ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO. Ann Oncol. 2020;31(3):334\u201351.","journal-title":"Ann Oncol"},{"issue":"10","key":"15429_CR6","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/s41575-022-00620-y","volume":"19","author":"P Johnson","year":"2022","unstructured":"Johnson P, Zhou Q, Dao DY, et al. Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2022;19(10):670\u201381.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7","key":"15429_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0235576","volume":"15","author":"C Koch","year":"2020","unstructured":"Koch C, Bette T, Waidmann O, et al. AFP ratio predicts HCC recurrence after liver transplantation. PLoS One. 2020;15(7):e0235576.","journal-title":"PLoS One"},{"issue":"17","key":"15429_CR8","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1097\/CM9.0000000000002380","volume":"136","author":"M Shao","year":"2023","unstructured":"Shao M, Tao Q, Xu Y, et al. Glutamine synthetase-negative hepatocellular carcinoma has better prognosis and response to sorafenib treatment after hepatectomy. Chin Med J (Engl). 2023;136(17):2066\u201376.","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"15429_CR9","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12885-023-10503-3","volume":"23","author":"X Yang","year":"2023","unstructured":"Yang X, Ni H, Lu Z, et al. Mesenchymal Circulating tumor cells and Ki67: their mutual correlation and prognostic implications in hepatocellular carcinoma. BMC Cancer. 2023;23(1):10.","journal-title":"BMC Cancer"},{"issue":"8","key":"15429_CR10","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1158\/2159-8290.CD-19-0074","volume":"9","author":"M Ruiz de Galarreta","year":"2019","unstructured":"Ruiz de Galarreta M, Bresnahan E, Molina-S\u00e1nchez P, et al. \u03b2-Catenin activation promotes immune escape and resistance to Anti-PD-1 therapy in hepatocellular carcinoma. Cancer Discov. 2019;9(8):1124\u201341.","journal-title":"Cancer Discov"},{"issue":"2","key":"15429_CR11","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s11605-021-05107-w","volume":"26","author":"W Shuyao","year":"2022","unstructured":"Shuyao W, Mingyang B, Feifei M, et al. CK19 predicts recurrence and prognosis of HBV positive HCC. J Gastrointest Surgery. 2022;26(2):341\u201351.","journal-title":"J Gastrointest Surgery"},{"issue":"3","key":"15429_CR12","doi-asserted-by":"publisher","first-page":"e0151501","DOI":"10.1371\/journal.pone.0151501","volume":"11","author":"J Feng","year":"2016","unstructured":"Feng J, Zhu R, Chang C, et al. CK19 and glypican 3 expression profiling in the prognostic indication for patients with HCC after surgical resection. PLoS One. 2016;11(3):e0151501.","journal-title":"PLoS One[J]"},{"issue":"2","key":"15429_CR13","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/jcla.21733","volume":"29","author":"J-P Yu","year":"2015","unstructured":"Yu J-P, Xu X-G, Ma R-J, et al. Development of a clinical chemiluminescent immunoassay for serum GPC3 and simultaneous measurements alone with AFP and CK19 in diagnosis of hepatocellular carcinoma. J Clin Lab Analysis. 2015;29(2):85\u201393.","journal-title":"J Clin Lab Analysis"},{"issue":"11","key":"15429_CR14","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.3390\/jpm11111078","volume":"11","author":"C-W Lee","year":"2021","unstructured":"Lee C-W, Lin S-E, Yu M-C, et al. Does neutrophil to lymphocyte ratio have a role in identifying cytokeratin 19-Expressing hepatocellular carcinoma? J Personalized Medicine. 2021;11(11):1078.","journal-title":"J Personalized Medicine"},{"issue":"1","key":"15429_CR15","first-page":"6651397","volume":"2021","author":"X Zhang","year":"2021","unstructured":"Zhang X, Wu Z, Peng Y, et al. Correlationship between Ki67, VEGF, and p53 and hepatocellular carcinoma recurrence in liver transplant patients. BioMed Res International. 2021;2021(1):6651397.","journal-title":"BioMed Res International[J]"},{"issue":"4","key":"15429_CR16","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1111\/j.1478-3231.2005.01069.x","volume":"25","author":"A Schmitt-Graeff","year":"2005","unstructured":"Schmitt-Graeff A, Ertelt-Heitzmann V, Allgaier H-P, et al. Coordinated expression of Cyclin D1 and LEF-1\/TCF transcription factor is restricted to a subset of hepatocellular carcinoma. Liver International. 2005;25(4):839\u201347.","journal-title":"Liver International"},{"issue":"12","key":"15429_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-023-02208-1","volume":"40","author":"J Esp\u00edrito Santo","year":"2023","unstructured":"Esp\u00edrito Santo J, Ladeirinha A, Alarc\u00e3o A, et al. Hepatocellular carcinoma: tumor heterogeneity and recurrence after preoperative locoregional therapy. Med Oncol. 2023;40(12):340.","journal-title":"Med Oncol"},{"key":"15429_CR18","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.2147\/JHC.S336858","volume":"8","author":"M Deldar Abad Paskeh","year":"2021","unstructured":"Deldar Abad Paskeh M, Mirzaei S, Ashrafizadeh M, et al. Wnt\/\u03b2-Catenin signaling as a driver of hepatocellular carcinoma progression: an emphasis on molecular pathways. J Hepatocell Carcinoma. 2021;8:1415\u201344.","journal-title":"J Hepatocell Carcinoma[J]"},{"issue":"2","key":"15429_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03424-1","volume":"12","author":"A Xu","year":"2021","unstructured":"Xu A, Wang X, Luo J, et al. Overexpressed P75CUX1 promotes EMT in glioma infiltration by activating \u03b2-catenin. Cell Death Dis. 2021;12(2):157.","journal-title":"Cell Death Dis"},{"issue":"7","key":"15429_CR20","first-page":"436","volume":"34","author":"Q Pang","year":"2019","unstructured":"Pang Q, Hu W, Zhang X, et al. Wnt\/\u03b2-catenin signaling pathway-related proteins (DKK-3, \u03b2-catenin, and c-MYC) are involved in prognosis of nasopharyngeal carcinoma. Cancer Biother Radiopharm. 2019;34(7):436\u201343.","journal-title":"Cancer Biother Radiopharm"},{"key":"15429_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.831366","volume":"12","author":"Y Xu","year":"2022","unstructured":"Xu Y, Yu X, Sun Z, et al. Roles of lncRNAs mediating Wnt\/\u03b2-catenin signaling in HCC. Front Oncol. 2022;12:831366.","journal-title":"Front Oncol"},{"issue":"33","key":"15429_CR22","doi-asserted-by":"publisher","first-page":"e2308711","DOI":"10.1002\/advs.202308711","volume":"11","author":"F Chen","year":"2024","unstructured":"Chen F, Zhang K, Wang M, et al. VEGF-FGF signaling activates quiescent CD63(+) liver stem cells to proliferate and differentiate. Adv Sci (Weinh). 2024;11(33):e2308711.","journal-title":"Adv Sci (Weinh)"},{"issue":"4","key":"15429_CR23","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1136\/gutjnl-2012-304351","volume":"63","author":"O Govaere","year":"2014","unstructured":"Govaere O, Komuta M, Berkers J, et al. Keratin 19: a key role player in the invasion of human hepatocellular carcinomas. Gut. 2014;63(4):674\u201385.","journal-title":"Gut"},{"issue":"6","key":"15429_CR24","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1159\/000510522","volume":"9","author":"H Rhee","year":"2020","unstructured":"Rhee H, Kim H, Park YN. Clinico-radio-pathological and molecular features of hepatocellular carcinomas with keratin 19 expression. Liver Cancer. 2020;9(6):663\u201381.","journal-title":"Liver Cancer"},{"issue":"1","key":"15429_CR25","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s12072-023-10615-9","volume":"18","author":"C-L Yang","year":"2024","unstructured":"Yang C-L, Song R, Hu J-W, et al. Integrating single-cell and bulk RNA sequencing reveals CK19\u2009+\u2009cancer stem cells and their specific SPP1\u2009+\u2009tumor-associated macrophage niche in HBV-related hepatocellular carcinoma. Hepatol Int. 2024;18(1):73\u201390.","journal-title":"Hepatol Int"},{"issue":"03","key":"15429_CR26","doi-asserted-by":"publisher","first-page":"2530004","DOI":"10.1142\/S1793545825300046","volume":"18","author":"X Men","year":"2025","unstructured":"Men X, Liu F, Gong M, et al. Activatable fluorescent probes for imaging and diagnosis of hepatocellular carcinoma. J Innovative Opt Health Sciences. 2025;18(03):2530004.","journal-title":"J Innovative Opt Health Sciences[J]"},{"key":"15429_CR27","doi-asserted-by":"publisher","first-page":"53","DOI":"10.25259\/Cytojournal_109_2024","volume":"21","author":"X Liu","year":"2024","unstructured":"Liu X, Jiang D, Liu Y, et al. Crispr-Cas9-based long non-coding RNA interference and activation identified that the aberrant expression of Myc-regulated ST8SIA6 antisense RNA 1 promotes tumorigenesis and metastasis in hepatocellular carcinoma. Cytojournal. 2024;21:53.","journal-title":"Cytojournal"},{"key":"15429_CR28","doi-asserted-by":"publisher","first-page":"1581398","DOI":"10.3389\/fimmu.2025.1581398","volume":"16","author":"X Peng","year":"2025","unstructured":"Peng X, Liu Z, Luo C, et al. PSMD12 promotes hepatocellular carcinoma progression by stabilizing CDK1. Front Immunol. 2025;16:1581398.","journal-title":"Front Immunol[J]"},{"issue":"2","key":"15429_CR29","first-page":"355","volume":"63","author":"K Bai","year":"2017","unstructured":"Bai K, Cao Y, Huang Q, et al. Prognostic value of Ki67 expression for patients with surgically resected hepatocellular carcinoma: perspectives from a high incidence area. Clin Lab. 2017;63(2):355\u201364.","journal-title":"Clin Lab"},{"issue":"6","key":"15429_CR30","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1097\/JCMA.0000000000000540","volume":"84","author":"HJ Lei","year":"2021","unstructured":"Lei HJ, Wang SY, Chau IY, et al. Hepatoma upregulated protein and Ki-67 expression in resectable hepatocellular carcinoma. J Chin Med Assoc. 2021;84(6):623\u201332.","journal-title":"J Chin Med Assoc"},{"issue":"1","key":"15429_CR31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.prp.2011.10.005","volume":"208","author":"AB 3rd Farris","year":"2012","unstructured":"Farris AB 3rd, Dursun N, Dhanasekaran R, et al. Tumoral and angiogenesis factors in hepatocellular carcinoma after locoregional therapy. Pathol Res Pract. 2012;208(1):15\u201321.","journal-title":"Pathol Res Pract"},{"issue":"10","key":"15429_CR32","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1016\/j.tibtech.2025.04.009","volume":"43","author":"F Chen","year":"2025","unstructured":"Chen F, Wang Z, Yao H, et al. Large-scale manufacturing of human gallbladder epithelial cell products and derived hepatocytes via a chemically defined approach. Trends Biotechnol. 2025;43(10):2646\u201364.","journal-title":"Trends Biotechnol"},{"key":"15429_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2022.114410","volume":"249","author":"Y Tian","year":"2023","unstructured":"Tian Y, Xia J, Yang G, et al. A2aR inhibits fibrosis and the EMT process in silicosis by regulating Wnt\/\u03b2-catenin pathway. Ecotoxicol Environ Saf. 2023;249:114410.","journal-title":"Ecotoxicol Environ Saf"},{"issue":"6","key":"15429_CR34","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1007\/s11596-016-1673-9","volume":"36","author":"YJ Ren","year":"2016","unstructured":"Ren YJ, Huang T, Yu HL, et al. Expression of \u03b2-catenin protein in hepatocellular carcinoma and its relationship with alpha-fetoprotein. J Huazhong Univ Sci Technolog Med Sci. 2016;36(6):846\u201351.","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"issue":"12","key":"15429_CR35","doi-asserted-by":"publisher","first-page":"7511","DOI":"10.62347\/PLQF5135","volume":"16","author":"G Liu","year":"2024","unstructured":"Liu G, Long J, Liu C, et al. Development and verification of a nomogram for predicting portal vein tumor thrombosis in hepatocellular carcinoma. Am J Transl Res. 2024;16(12):7511\u201320.","journal-title":"Am J Transl Res"},{"issue":"12","key":"15429_CR36","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1111\/jvh.13886","volume":"30","author":"Q Ning","year":"2023","unstructured":"Ning Q, Yang T, Guo X, et al. CHB patients with rtA181T-mutated HBV infection are associated with higher risk hepatocellular carcinoma due to increases in mutation rates of tumour suppressor genes. J Viral Hepatitis. 2023;30(12):951\u20138.","journal-title":"J Viral Hepatitis"},{"key":"15429_CR37","doi-asserted-by":"publisher","DOI":"10.36922\/cp.5758","author":"Y Zarlashat","year":"2024","unstructured":"Zarlashat Y, A T, Hussain S. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in hepatocellular carcinoma: from inflammation to clinical applications. CP. 2024. https:\/\/doi.org\/10.36922\/cp.5758.","journal-title":"CP"},{"issue":"184","key":"15429_CR38","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.24976\/Discov.Med.202436184.97","volume":"36","author":"L Zhidan","year":"2024","unstructured":"Zhidan L, Yongxia Z. GSK-126 enhances all-trans-retinoic acid (ATRA) response in hepatocellular carcinoma (HCC) by upregulating\u2009<\u2009i\u2009>\u2009RARG<\/i\u2009>\u2009expression. Discov Med. 2024;36(184):1041\u201353.","journal-title":"Discov Med"},{"key":"15429_CR39","doi-asserted-by":"publisher","first-page":"114545","DOI":"10.1016\/j.intimp.2025.114545","volume":"154","author":"B Liu","year":"2025","unstructured":"Liu B, Li C, He S, et al. Ubiquitin-conjugating enzyme E2S (UBE2S) as a prognostic biomarker and regulator of tumorigenesis in osteosarcoma. Int Immunopharmacology. 2025;154:114545.","journal-title":"Int Immunopharmacology"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15429-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-15429-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15429-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T10:36:21Z","timestamp":1768991781000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-025-15429-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15429"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-15429-6","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"15 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of the First Affiliated Hospital of Hainan Medical University (Approval Number: HYLL-2024-827). Informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"96"}}